Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zunino

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Life Sciences|January 1, 1991
The role of topoisomerase II in drug resistanceP De Isabella, G Capranico, F Zunino
European Journal of Biochemistry|April 17, 1978
The interaction of daunomycin with polydeoxynucleotidesD R Phillips, A DiMarco, F Zunino
The Journal of Biological Chemistry|October 7, 1994
Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrinG Capranico, M Palumbo, S Tinelli, et al.
Anti-Cancer Drugs|December 1, 1994
Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor typesP Perego, G Capranico, R Supino, et al.
Cell Biology International Reports|December 1, 1985
Influence of calcium and calcium-modulating agents on differentiation of murine erythroleukaemia cellsR Supino, N Gibelli, I Galatulas, et al.
Cancer Letters|May 1, 1991
Modulation of epidermal growth factor receptor tyrosine phosphorylation by tumor necrosis factorL Guazzoni, P Perego, P Banfi, et al.
Anticancer Research|September 1, 1986
Sensitivity to anthracyclines in P388/dx leukaemia cellsR Bossa, T Dasdia, I Galatulas, et al.
Investigational New Drugs|November 1, 1990
Evaluation of a platinum-doxorubicin complex in experimental tumor systemsF Zunino, G Pratesi, F Formelli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in miceG Pratesi, L Gianni, C Manzotti, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1992
Current approaches to new drug development in cancer chemotherapyF Zunino, G Capranico, G Pratesi, et al.
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Life Sciences|January 1, 1991
The role of topoisomerase II in drug resistanceP De Isabella, G Capranico, F Zunino
European Journal of Biochemistry|April 17, 1978
The interaction of daunomycin with polydeoxynucleotidesD R Phillips, A DiMarco, F Zunino
The Journal of Biological Chemistry|October 7, 1994
Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrinG Capranico, M Palumbo, S Tinelli, et al.
Anti-Cancer Drugs|December 1, 1994
Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor typesP Perego, G Capranico, R Supino, et al.
Cell Biology International Reports|December 1, 1985
Influence of calcium and calcium-modulating agents on differentiation of murine erythroleukaemia cellsR Supino, N Gibelli, I Galatulas, et al.
Cancer Letters|May 1, 1991
Modulation of epidermal growth factor receptor tyrosine phosphorylation by tumor necrosis factorL Guazzoni, P Perego, P Banfi, et al.
Anticancer Research|September 1, 1986
Sensitivity to anthracyclines in P388/dx leukaemia cellsR Bossa, T Dasdia, I Galatulas, et al.
Investigational New Drugs|November 1, 1990
Evaluation of a platinum-doxorubicin complex in experimental tumor systemsF Zunino, G Pratesi, F Formelli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in miceG Pratesi, L Gianni, C Manzotti, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1992
Current approaches to new drug development in cancer chemotherapyF Zunino, G Capranico, G Pratesi, et al.
Pageof 21